Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Intelligence Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

Intelligence Hub About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN; CLAVULANATE POTASSIUM) | LOERadar

Viewing data from:

AMOXICILLIN AND CLAVULANATE POTASSIUM

ANDA

AMOXICILLIN; CLAVULANATE POTASSIUM | A217805 | MICRO LABS LTD

1 strength0 unique patents0 unique exclusivities

Products (1)

#001 — 600MG/5ML;EQ 42.9MG BASE/5ML

0 patents0 exclusivities▴

FOR SUSPENSION;ORAL | Approved: Dec 8, 2023

No patent or exclusivity listings for this strength.